Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

The tumor microenvironment (TME) consists of mediators surrounding a tumor, including diverse cell types, blood vessels, and ...

Patients with metastatic or unresectable gastric cancer are usually given 5-fluorouracil (5-FU) and platinum-based chemotherapy, but patients with advance disease usually have a poor prognosis. The ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue. A new “Tumor Activated Therapy™” in development at the small ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

Bolt Biotherapeutics, in partnership with Toray Industries, has announced a collaboration focused on developing a novel immune-stimulating antibody conjugate (ISAC) targeting Caprin-1, a ...

Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized hematologic cancer treatment, but its efficacy in solid tumors remains limited by poor infiltration into the complex tumor ...